Arrowhead Pharmaceuticals Corp. | Balance Sheet
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
28,144.70
154,163.60
98,754.30
85,366.40
65,608.10
76,533.40
Total Accounts Receivable
83.70
-
-
75.00
67.80
327.40
Other Current Assets
615.40
637.10
4,116.90
5,061.10
2,227.00
1,907.80
Total Current Assets
28,843.70
154,800.80
102,871.20
90,502.50
67,902.90
78,768.60
Net Property, Plant & Equipment
3,513.20
3,872.80
4,526.80
15,386.80
15,513.00
13,935.40
Total Investments and Advances
-
23,088.30
-
-
-
-
Intangible Assets
3,240.50
1,013.50
24,824.10
22,164.90
20,464.40
18,764
Other Assets
1,732.20
41.40
45.80
122.30
141.90
141.90
Total Assets
37,329.60
182,816.80
132,267.90
128,176.50
104,022.30
111,610
ST Debt & Current Portion LT Debt
1,192.90
264.00
217.50
194.30
208.50
Accounts Payable
1,199.60
2,579.50
5,031.70
12,232.90
4,076.50
Other Current Liabilities
6,332.50
9,003.60
10,651.30
13,216.60
14,416.00
Total Current Liabilities
8,725.00
11,847.00
15,900.60
25,643.80
18,701.00
Long-Term Debt
1,111.10
758.30
540.80
2,533.50
2,325.00
Provision for Risks & Charges
-
3,970.90
5,862.50
-
-
Other Liabilities
1,758.70
255.20
342.50
4,975.00
2,129.10
Total Liabilities
11,594.80
16,831.50
22,646.30
33,152.20
23,155.10
Common Equity (Total)
27,498.70
166,540.40
110,176.80
95,579.40
81,422.40
Total Shareholders' Equity
27,498.70
166,540.40
110,176.80
95,579.40
81,422.40
Total Equity
25,734.80
165,985.30
109,621.60
95,024.30
80,867.20
Liabilities & Shareholders' Equity
37,329.60
182,816.80
132,267.90
128,176.50
104,022.30
Accumulated Minority Interest
1,763.90
555.20
555.20
555.20
555.20
Preferred Stock (Carrying Value)
0.00
0.00
0.00
0.00
-
About Arrowhead Pharmaceuticals
View Profile
